OS Therapies OSTX Chief Operating Decision Maker — Other Nonoperating Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by OS Therapies in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingExpense.
The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about OS Therapies's chief operating decision maker — other nonoperating expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OS Therapies's chief operating decision maker — other nonoperating expense?
- OS Therapies (OSTX) reported chief operating decision maker — other nonoperating expense of $153.59K in Q1 2026.
- How has OS Therapies's chief operating decision maker — other nonoperating expense changed year-over-year?
- OS Therapies's chief operating decision maker — other nonoperating expense decreased by 58.3% year-over-year, from $368.25K to $153.59K.
- What does chief operating decision maker — other nonoperating expense mean?
- Represents costs or losses incurred outside of the primary clinical and administrative operations, such as miscellaneous fees or non-recurring charges. Monitoring these expenses helps identify non-core financial drains on the company's resources. It is essential for understanding the total cost structure beyond core R&D.